![incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1](https://www.preprints.org/frontend/picture/ms_xml/manuscript/28233dba55c7b404c1a8e0b10dd5de8e/preprints-107031-g002.png)
incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1
Description
Moulton CD, Hopkins CWP, Ismail K, Stahl D
![incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1](https://endoconsult.b-cdn.net/wp-content/uploads/mechanism-of-action-of-incretin-mim.png)
The pathogenesis of nonarteritic anterior ischemic optic neuropathy
![incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1](https://www.researchgate.net/publication/370926483/figure/fig3/AS:11431281185385543@1693619319358/Structures-of-formulations-of-GLP-1-receptor-agonists-14-15-19-21-26-a-GLP-1-b.png)
Noom's microdose program uses 0.1-0.6mg doses (up to 25% of standard maintenance) combined with behavioral coaching
![incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13098-025-01623-w/MediaObjects/13098_2025_1623_Figa_HTML.png)
Endocrinology 2008
![incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
But it doesnt stop there
![incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1](https://diatribe.org/_next/image?url=https%3A%2F%2Fapi.diatribe.org%2Fsites%2Fdefault%2Ffiles%2Fstyles%2Fcontent_teaser_large%2Fpublic%2F2026-02%2Fistock-2025836701.jpg%3Fitok%3DrddZjZG5&w=3840&q=75)
Under the guidance of a qualified healthcare provider, these medications are prescribed at doses significantly lower than those typically used for diabetes or major weight loss
![incretin mimetic agents glp 1 receptor agonists A Brief Review of Mimetics Intended for the Management of Diabetes and Associated Comorbidities[v1] Mechanism of action of GLP-1](https://www.researchgate.net/publication/363540230/figure/fig1/AS:11431281091472195@1666458880001/The-mechanisms-of-dual-incretin-receptor-agonists-Glucagon-like-peptide-1-GLP-1-and.png)
